Gadofosveset Trisodium Patent Expiration
Gadofosveset Trisodium is Used for imaging mammalian tissues using MRI technology. It was first introduced by Lantheus Medical Imaging Inc
Gadofosveset Trisodium Patents
Given below is the list of patents protecting Gadofosveset Trisodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ablavar | US6676929 | Diagnostic imaging contrast agents with extended blood retention |
May 04, 2020
(Expired) | Lantheus Medcl |
| Ablavar | US7060250 | Diagnostic imaging contrast agents with extended blood retention |
May 26, 2015
(Expired) | Lantheus Medcl |
| Ablavar | US7229606 | Diagnostic imaging contrast agents with extended blood retention |
May 26, 2015
(Expired) | Lantheus Medcl |
| Ablavar | US8017105 | Diagnostic imaging contrast agents with extended blood retention |
May 26, 2015
(Expired) | Lantheus Medcl |
| Ablavar | US7011815 | Diagnostic imaging contrast agents with extended blood retention |
Feb 01, 2015
(Expired) | Lantheus Medcl |
| Ablavar | US8394356 | Diagnostic imaging contrast agents with extended blood retention |
Feb 01, 2015
(Expired) | Lantheus Medcl |
Gadofosveset Trisodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List